Cargando…

Cardioprotection in right heart failure

Ischaemic and pharmacological conditioning of the left ventricle is mediated by the activation of signalling cascades, which finally converge at the mitochondria and reduce ischaemia/reperfusion (I/R) injury. Whereas the molecular mechanisms of conditioning in the left ventricle are well characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Boengler, Kerstin, Schlüter, Klaus‐Dieter, Schermuly, Ralph Theo, Schulz, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680005/
https://www.ncbi.nlm.nih.gov/pubmed/31995639
http://dx.doi.org/10.1111/bph.14992
_version_ 1783612375424827392
author Boengler, Kerstin
Schlüter, Klaus‐Dieter
Schermuly, Ralph Theo
Schulz, Rainer
author_facet Boengler, Kerstin
Schlüter, Klaus‐Dieter
Schermuly, Ralph Theo
Schulz, Rainer
author_sort Boengler, Kerstin
collection PubMed
description Ischaemic and pharmacological conditioning of the left ventricle is mediated by the activation of signalling cascades, which finally converge at the mitochondria and reduce ischaemia/reperfusion (I/R) injury. Whereas the molecular mechanisms of conditioning in the left ventricle are well characterized, cardioprotection of the right ventricle is principally feasible but less established. Similar to what is known for the left ventricle, a dysregulation in signalling pathways seems to play a role in I/R injury of the healthy and failing right ventricle and in the ability/inability of the right ventricle to respond to a conditioning stimulus. The maintenance of mitochondrial function seems to be crucial in both ventricles to reduce I/R injury. As far as currently known, similar molecular mechanisms mediate ischaemic and pharmacological preconditioning in the left and right ventricles. However, the two ventricles seem to respond differently towards exercise‐induced preconditioning. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc
format Online
Article
Text
id pubmed-7680005
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76800052020-11-27 Cardioprotection in right heart failure Boengler, Kerstin Schlüter, Klaus‐Dieter Schermuly, Ralph Theo Schulz, Rainer Br J Pharmacol Review Articles Ischaemic and pharmacological conditioning of the left ventricle is mediated by the activation of signalling cascades, which finally converge at the mitochondria and reduce ischaemia/reperfusion (I/R) injury. Whereas the molecular mechanisms of conditioning in the left ventricle are well characterized, cardioprotection of the right ventricle is principally feasible but less established. Similar to what is known for the left ventricle, a dysregulation in signalling pathways seems to play a role in I/R injury of the healthy and failing right ventricle and in the ability/inability of the right ventricle to respond to a conditioning stimulus. The maintenance of mitochondrial function seems to be crucial in both ventricles to reduce I/R injury. As far as currently known, similar molecular mechanisms mediate ischaemic and pharmacological preconditioning in the left and right ventricles. However, the two ventricles seem to respond differently towards exercise‐induced preconditioning. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc John Wiley and Sons Inc. 2020-03-09 2020-12 /pmc/articles/PMC7680005/ /pubmed/31995639 http://dx.doi.org/10.1111/bph.14992 Text en © 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review Articles
Boengler, Kerstin
Schlüter, Klaus‐Dieter
Schermuly, Ralph Theo
Schulz, Rainer
Cardioprotection in right heart failure
title Cardioprotection in right heart failure
title_full Cardioprotection in right heart failure
title_fullStr Cardioprotection in right heart failure
title_full_unstemmed Cardioprotection in right heart failure
title_short Cardioprotection in right heart failure
title_sort cardioprotection in right heart failure
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680005/
https://www.ncbi.nlm.nih.gov/pubmed/31995639
http://dx.doi.org/10.1111/bph.14992
work_keys_str_mv AT boenglerkerstin cardioprotectioninrightheartfailure
AT schluterklausdieter cardioprotectioninrightheartfailure
AT schermulyralphtheo cardioprotectioninrightheartfailure
AT schulzrainer cardioprotectioninrightheartfailure